Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lens fiber major intrinsic protein (AQP0) is the principal membrane protein in lens fiber cells, essential for maintaining lens transparency and homeostasis. As a member of the aquaporin family, it functions primarily as a water channel, enabling controlled water flux through lens fiber cell membranes. Unlike other aquaporins, its water permeability is lower and tightly regulated by post-translational modifications and interactions with proteins like calmodulin. Besides water transport, AQP0 acts as an adhesive molecule, forming cell–cell junctions crucial for lens spatial organization and stability. Disruption of AQP0’s function—by genetic mutation or abnormal post-translational changes—leads to impaired lens fiber cell communication and morphology, resulting in congenital cataract and other lens defects. AQP0 is not considered a therapeutic target, as there are currently no drugs in clinical use targeting this protein[1][2][3][4][5].
Not applicable; there are no approved drugs acting directly via AQP0. Basic mechanisms if targeted would include modulation of water transport or interference with cell–cell adhesion[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lens fiber major intrinsic protein (AQP0).